I don't think that is the right question. Bioavailability is measured as delivery to the bloodstream. If the liver is the worst place for Delta9 THC, the bloodstream is the second worst place for Delta9 THC. Unless one is trying to get high.
I hadn't thought of it like that Rad. We want them in the central nervous system and in the lymphatic system, don't we? Thats why we use carrier oils and lecithin.
Good points.
I completely disagree with these statements. From my understanding when tumors become large enough they need to develop their own blood supply, subsequently, I would think that if you're trying to treat this scenario then getting it in to your bloodstream is the best place for delta-9-thc, preferably with regular dosing so the delta-9-thc is replaced as it's metabolised.